Variants and haplotypes of TCF7L2 are associated with β-cell function in patients with newly diagnosed type 2 diabetes: the verona newly diagnosed type 2 diabetes study (VNDS) 1

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 2, 2011, Pages

  Bonetti, S ^a   Trombetta, M ^a   Malerba, G ^b   Boselli, L ^a   Trabetti, E ^b   Muggeo, M ^a   Stoico, V ^a   Negri, C ^a   Pignatti, P F ^b   Bonora, E ^a   Bonadonna, R C ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTAMATE DECARBOXYLASE; INSULIN; TRANSCRIPTION FACTOR 7 LIKE 2;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CELL FUNCTION; CLINICAL ASSESSMENT; CLINICAL STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST; DIET RESTRICTION; EUGLYCEMIC INSULIN CLAMP; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC VARIATION; GLUCOSE TOLERANCE TEST; HAPLOTYPES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PANCREATIC FUNCTION TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 79951699239     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1677     Document Type: Article

References (20)

1. van Tilburg J, van Haeften TW, Pearson P, Wijmenga C 2001 Defining the genetic contribution of type 2 diabetes mellitus. J Med Genet 38:569-578
2. McCarthy MI, Zeggini E 2009 Genome-wide association studies in type 2 diabetes. Curr Diab Rep 9:164-171
3. Ridderstråle M, Groop L 2009 Genetic dissection of type 2 diabetes. Mol Cell Endocrinol 297:10-17
4. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, Lindgren CM, Mägi R, Morris AP, Randall J, Johnson T, Elliott P, Rybin D, Thorleifsson G, Steinthorsdottir V, Henneman P, Grallert H, Dehghan A, Hottenga JJ, Franklin CS, Navarro P, et al. 2010 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105-116
5. Pearson ER 2009 Translating TCF7L2: from gene to function. Diabetologia 52:1227-1230
6. Cauchi S, Meyre D, Dina C, Choquet H, Samson C, Gallina S, Balkau B, Charpentier G, Pattou F, Stetsyuk V, Scharfmann R, Staels B, Frühbeck G, Froguel P 2006 Transcription factor TCF7L2 genetic study in the French population: expression in human β-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 55:2903-2908 (Pubitemid 44923694)
7. Rees SD, Bellary S, Britten AC, O'Hare JP, Kumar S, Barnett AH, Kelly MA 2008 Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a U.K.-resident South Asian population. BMC Med Genet 9:8
8. Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, Sjögren M, Florez JC, Almgren P, Isomaa B, Orho-Melander M, Lindblad U, Daly MJ, Tuomi T, Hirschhorn JN, Ardlie KG, Groop LC, Altshuler D 2006 Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55:2890-2895 (Pubitemid 44923692)
9. Pascoe L, Frayling TM, Weedon MN, Mari A, Tura A, Ferrannini E, Walker M 2008 β-Cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles. Diabetologia 51:1989-1992
10. Pilgaard K, Jensen CB, Schou JH, Lyssenko V, Wegner L, Brøns C, Vilsboll T, Hansen T, Madsbad S, Holst JJ, Volund A, Poulsen P, Groop L, Pedersen O, Vaag AA 2009 The T allele of rs7903146 TCF7L2is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia 52:1298-1307
11. Bonadonna RC, Heise T, Arbet-Engels C, Kapitza C, Avogaro A, Grimsby J, Zhi J, Grippo JF, Balena R 2010 Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. J Clin Endocrinol Metab 95:5028-5036
12. Monauni T, Zenti MG, Cretti A, Daniels MC, Targher G, Caruso B, Caputo M, McClain D, Del Prato S, Giaccari A, Muggeo M, Bonora E, Bonadonna RC 2000 Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 49:926-935 (Pubitemid 30349414)
13. Calí AM, Bonadonna RC, Trombetta M, Weiss R, Caprio S 2008 Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. J Clin Endocrinol Metab 93:1767-1773 (Pubitemid 351656516)
14. Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, Bonadonna R 2005 β-Cell function across the spectrum of glucose tolerance in obese youth. Diabetes 54:1735-1743 (Pubitemid 40774888)
15. Cobelli C, Toffolo GM, DallaMan C, Campioni M, Denti P, Caumo A, Butler P, Rizza R 2007 Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 293:E1-E15 (Pubitemid 47105910)
16. Mari A, Camastra S, Toschi E, Giancaterini A, Gastaldelli A, Mingrone G, Ferrannini E 2001 A model for glucose control of insulin secretion during 24 h of free living. Diabetes 50(Suppl 1):S164-S168 (Pubitemid 32148245)
17. Gambino R, Bo S, Gentile L, Musso G, Pagano G, Cavallo-Perin P, Cassader M 2010 Transcription factor 7-like 2 (TCF7L2) polymorphism and hyperglycemia in an adult Italian population-based cohort. Diabetes Care 33:1233-1235
18. Helgason A, Pálsson S, Thorleifsson G, Grant SF, Emilsson V, Gunnarsdottir S, Adeyemo A, Chen Y, Chen G, Reynisdottir I, Benediktsson R, Hinney A, Hansen T, Andersen G, Borch-Johnsen K, Jorgensen T, Schäfer H, Faruque M, Doumatey A, Zhou J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Sigurdsson G, Hebebrand J, Pedersen O, Thorsteinsdottir U, Gulcher JR, Kong A, Rotimi C, Stefánsson K 2007 Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39:218-225
19. Lyssenko V 2008 The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update. Curr Opin Clin Nutr Metab Care 11:385-392
20. Lehman DM, Hunt KJ, Leach RJ, Hamlington J, Arya R, Abboud HE, Duggirala R, Blangero J, Göring HH, Stern MP 2007 Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes 56:389-393